Reduction in renal outcomes with selective endothelin receptor antagonist in patients with diabetic kidney disease

3' education - Apr. 17, 2019 - Melbourne, Australia

Educational information

This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.

Faculty

Prof. dr. Hiddo Lambers Heerspink is clinical pharmacologist and works at the faculty Medical Sciences, University Groningen, the Netherlands

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the SONAR results

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.